Itanz Technologies Limited (ITANZ) reported earnings per share of PKR 3.20 for FY25, compared to earnings per share of PKR 1.47 in FY24. The Company reported net revenue of PKR 242 million and a net profit of PKR 161 million during H1 FY26. Approximately 90% of earnings are derived from international markets, comprising SaaS product revenue and consulting income. The Company’s core verticals include the public sector (Australia), healthcare (UK), and the financial sector (Pakistan and regional markets). Management is gradually shifting the revenue base away from pure consulting toward Annual Recurring Revenue ARR and SaaS models to enhance bottom line profitability.
The Company is in the final stages of acquiring its international subsidiaries (in the UK, Australia, New Zealand, and the Middle East). These acquisitions are approximately 90% complete and are expected to be finalized before June 2026. The flagship Citizen Services product caters to city councils.
Management is currently targeting a market segment of 50 to 70 councils in Western Australia. In the UK healthcare segment, Itanz offers an AI based document automation tool for the GP market. The solution is NHS certified, and the Company is currently onboarding 10 to 15 hospitals per month. A strong pipeline is expected over the next 12 months, supported by a core banking contract with the Bank of Azad Jammu & Kashmir and an exclusive AI/CRM partnership with Salesforce for the Pakistani market. The company secured over $6 million in contracts during H1FY26 and has an additional $5 million in Letters of Intent targeted for completion within the current FY26.
Management has decided to repatriate dividends from international entities on a quarterly basis starting from the next fiscal year.
Important Disclosures
Disclaimer: This report has been prepared by Chase Securities Pakistan (Private) Limited and is provided for information purposes only. Under no circumstances, this is to be used or considered as an offer to sell or solicitation or any offer to buy. While reasonable care has been taken to ensure that the information contained in this report is not untrue or misleading at the time of its publication, Chase Securities makes no representation as to its accuracy or completeness and it should not be relied upon as such. From time to time, Chase Securities and/or any of its officers or directors may, as permitted by applicable laws, have a position, or otherwise be interested in any transaction, in any securities directly or indirectly subject of this report Chase Securities as a firm may have business relationships, including investment banking relationships with the companies referred to in this report This report is provided only for the information of professional advisers who are expected to make their own investment decisions without undue reliance on this report and Chase Securities accepts no responsibility whatsoever for any direct or indirect consequential loss arising from any use of this report or its contents At the same time, it should be noted that investments in capital markets are also subject to market risks This report may not be reproduced, distributed or published by any recipient for any purpose.